| HOME >> MEDICINE >> TECHNOLOGY |
a liquidator or provisional liquidator is appointed to any member of the ChemGenex Group;(J)
a court makes an order for the winding up of any member of the ChemGenex Group;(K)
an administrator is appointed to any member of the ChemGenex Group under section 436A, 436B or 436C of the Corporations Act;(L)
any member of the ChemGenex Group executes a deed of company arrangement; or(M)
a receiver, or a receiver and manager, is appointed in relation to the whole, or a substantial part, of the property of any member of the ChemGenex Group.(ii)
During the Condition Period:(A)
none of the events listed in Condition (e)(i) happens;(B)
no member of the ChemGenex Group undertakes a transaction similar to any of those referred to in Condition (e)(i) under the law of its place of incorporation;(C)
no administrator, or person performing a function similar to an administrator appointed under section 436A, 436B or 436C of the Corporations Act, is appointed in respect of a member of the ChemGenex Group under a provision equivalent to any of those sections of the Corporations Act under the law of the place of incorporation of the subsidiary;(D)
no member of the ChemGenex Group enters into an arrangement similar to that referred to in Condition (e)(i)(L), or any other composition with creditors, under the law of the place of incorporation of the subsidiary; (E)
no member of the ChemGenex Group issues or grants:(aa)
any performance rights or other equity-based incentive; or (bb)
any security which is convertible into ChemGenex shares and which is not referenced in any of the preceding paragraphs or sub-paragraphs of this Appendix;(F)
ChemGenex does not declare or pay any dividend or other distribution;(G)
no amendment is made to the constitution of ChemGenex;(H)
in relation to Unlisted Option Cancellation Letters:(aa)
the ASX g
'/>"/>
| SOURCE Cephalon, Inc.; ChemGenex Pharmaceuticals Limited Copyright©2010 PR Newswire. All rights reserved |